Aculys: Aculys Pharma starts Phase III EDS therapy trial
The trial will assess pitolisant's efficacy and safety in Japanese OSAS patients who are complaining of EDS. The post Aculys Pharma starts Phase III EDS therapy trial appeared first on Clinical Trials Arena.
Read full article »
Aculys is a Japan-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurological and psychiatric diseases.
Read more